Quantum Biopharma Ltd. submitted a Form 6-K to report its activities as a foreign private issuer for January 2025. The filing was signed by CFO Donal Carroll on January 17, 2025, confirming compliance with SEC regulations.
AI Assistant
QUANTUM BIOPHARMA LTD
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.